Similar to other tumor models, CLL cells take advantage and promote the upregulation of a regulatory feedback inhibition, including among other the PD-L1/PD-1 axis, to evade immune-attack and maintain tolerance. Here, PDCD1 is linked to B-cell chronic lymphocytic leukemia.